There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Check-Cap (CHEK – Research Report), Axsome Therapeutics (AXSM – Research Report) and Oncolytics Biotech (ONCY – Research Report) with bullish sentiments. Check-Cap (CHEK) In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Check-Cap, with a price target of $3.00. The company's shares closed last Friday at $0.38, close to its 52-week low of $0.36. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-check-cap-chek-axsome-therapeutics-axsm?utm_source=advfn.com&utm_medium=referral
Oncolytics Biotech (NASDAQ:ONCY)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Oncolytics Biotech Charts.
Oncolytics Biotech (NASDAQ:ONCY)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Oncolytics Biotech Charts.